MedPath
HSA Approval

Obagi Nu-Derm Blender

SIN13519P

Obagi Nu-Derm Blender

Obagi Nu-Derm Blender

August 13, 2008

NEOASIA (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNEOASIA (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D11AX11

hydroquinone

Manufacturer Information

NEOASIA (S) PTE LTD

Pure Tek Corporation

Active Ingredients

Hydroquinone

4%

Hydroquinone

Documents

Package Inserts

Obagi Nu-Derm PI.pdf

Approved: July 25, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.